Daliresp for COPD Exacerbation Risk Reduction

Daliresp is the brand name for roflumilast, an oral phosphodiesterase-4 inhibitor used to reduce flare-ups in adults with severe chronic obstructive pulmonary disease associated with chronic bronchitis and a history of exacerbations. It lowers inflammatory activity in the lungs; it is not a rescue medicine for sudden breathlessness and does not replace an inhaler prescribed for an acute attack.

• Indication: maintenance treatment to lower the risk of COPD exacerbations in the appropriate adult patient.
• Usual regimen: one tablet by mouth once daily as directed by the prescriber; treatment is continued regularly rather than taken only when symptoms worsen.
• Do not use: in moderate or severe liver impairment, or after a prior hypersensitivity reaction to roflumilast.
• Urgent concerns: report major mood changes, suicidal thoughts, marked unintended weight loss, severe rash, swelling, or trouble breathing promptly.

What is Daliresp and how does it work for COPD?

Daliresp contains roflumilast, a selective PDE4 inhibitor and anti-inflammatory medicine. By inhibiting phosphodiesterase-4, it increases intracellular cyclic AMP in inflammatory cells and helps reduce inflammation that contributes to chronic bronchitis-related COPD exacerbations. It does not open the airways quickly, so it should not be used to treat acute bronchospasm, a sudden wheeze, or an asthma attack.

For people comparing treatment options, buy Daliresp only with a valid prescription after a clinician has confirmed that this medicine fits the COPD pattern and current treatment plan. Daliresp price can vary by tablet strength, pack size, pharmacy, insurance coverage, and availability of a generic roflumilast product.

Who may use Daliresp?

Daliresp is intended for adults with severe COPD related to chronic bronchitis who have experienced exacerbations. Chronic bronchitis commonly involves persistent cough and mucus production, while COPD can also include airflow limitation, exertional shortness of breath, wheezing, and recurrent chest infections. A prescriber may use roflumilast alongside bronchodilators or inhaled maintenance therapy; it is not a substitute for smoking cessation, vaccination, pulmonary rehabilitation, or an individualized action plan.

What is the usual Daliresp dosage and how is it taken?

The maintenance dose is commonly roflumilast 500 mcg once daily, swallowed whole with water, with or without food, at approximately the same time each day. Some clinicians use a short introductory period with 250 mcg once daily to improve tolerability before the regular dose; follow the directions printed on the prescription rather than changing the schedule independently. Do not crush, split, or take extra tablets to make up a missed dose.

When the prescribed strengths are available, buy Daliresp 250 mcg and buy Daliresp 500 mcg only according to the prescription plan. The Daliresp price for each strength may differ, so confirm the exact quantity and strength before dispensing.

What happens if a Daliresp dose is missed?

Take a missed tablet when remembered unless it is close to the next scheduled dose. If it is nearly time for the next dose, skip the missed tablet and resume the normal once-daily schedule. Do not take two doses at once. If several doses are missed, ask the prescriber or pharmacist how to restart safely.

What are the most common side effects of Daliresp?

The most common adverse effects include diarrhea, nausea, decreased appetite, weight loss, headache, back pain, dizziness, tremor, insomnia, and upper respiratory symptoms. These effects can be most noticeable early in treatment. Regular weight checks are important because clinically meaningful weight loss can occur; contact the prescriber if weight loss is unexplained, persistent, or concerning.

Serious neuropsychiatric effects are less common but important. New or worsening anxiety, depression, agitation, unusual behavior, insomnia, suicidal thinking, or a suicide attempt requires prompt medical attention. Families and caregivers should also be aware of these changes, particularly in a person with a past history of depression or suicidal thoughts.

What are the long-term side effects of Daliresp?

Long-term treatment requires periodic review of body weight, appetite, mood, sleep, liver history, and the overall frequency of COPD exacerbations. Continued diarrhea or poor appetite can contribute to weight loss and dehydration. A clinician should reassess benefit and tolerability rather than assuming that a chronic cough or worsening breathing is a medicine effect; COPD itself and respiratory infections can also change over time.

Which medicines interact with Daliresp?

Roflumilast is affected by medicines that alter CYP3A4 and CYP1A2 metabolism. Rifampin, carbamazepine, phenytoin, and phenobarbital may reduce roflumilast exposure and can make treatment less effective. Certain strong metabolic inhibitors, including ketoconazole, fluvoxamine, enoxacin, and cimetidine, may increase exposure and side-effect risk. Give the prescriber a complete list of prescription medicines, inhalers, nonprescription products, vitamins, and herbal preparations before treatment starts.

How does Daliresp interact with alcohol?

Alcohol is not a standard direct contraindication, but it can worsen dizziness, nausea, sleep disturbance, low mood, poor appetite, or dehydration in some people. Heavy alcohol use can also complicate assessment of liver health and mental-health symptoms. Discuss regular or heavy alcohol use with the prescriber before using roflumilast, and avoid driving or hazardous tasks if dizziness occurs.

Is Daliresp safe during pregnancy or breastfeeding?

Tell the prescriber if pregnancy is planned, suspected, or confirmed, or if breastfeeding is being considered. Human pregnancy and lactation decisions require an individual risk-benefit discussion because untreated respiratory disease also carries health risks. Do not start, stop, or restart Daliresp during pregnancy without professional guidance.

Who should not take Daliresp?

Do not take roflumilast with moderate or severe hepatic impairment. Use careful clinical judgment in people with a history of depression, suicidal behavior, significant unintended weight loss, or conditions that make low body weight especially hazardous. Tell the clinician about kidney, liver, immune, or psychiatric conditions and any allergy to medicines before treatment.

What should be done in a Daliresp overdose?

Too much roflumilast may cause nausea, vomiting, palpitations, lightheadedness, sweating, or changes in mood or alertness. Seek urgent medical advice or contact emergency services or a poison-control resource after a suspected overdose, especially if severe symptoms occur. Keep the medicine in its original container so the tablet strength and amount can be identified.

How should Daliresp be stored and obtained?

Store tablets at room temperature in the original, tightly closed container, away from excess heat, moisture, and children. Do not use tablets that are damaged or beyond their expiration date. If deciding where to buy Daliresp, verify the prescribed strength and use a licensed pharmacy. The final Daliresp price should be checked for the exact prescription because discounts, coverage, and quantity can change.

This information is educational and does not replace individualized diagnosis, prescribing, or emergency care. Follow the directions supplied by the treating clinician and pharmacist.